RAD23BP1

Across TCGA pan-cancer cohorts, RAD23BP1 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated RAD23BP1 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RAD23BP1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RAD23BP1 expression acts as an unfavorable survival marker, although some lineages such as KIRC and CHOL show a favorable association.

ACC, MESO, and KIRC are the cancer types where RAD23BP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.474	0.827	<.001	101	view →
MESO	OS	Tertile	II,III,IV	0.406	0.679	<.001	97	view →
KIRC	OS	Tertile	All	0.714	0.521	<.001	62	view →
DLBC	OS	Quartile	All	0.685	1.000	.004	36	view →
CHOL	DFS	Tertile	All	0.794	0.341	.010	25	view →
SKCM	DFS	Median	All	0.317	0.145	.002	22	view →
LUSC	OS	Quartile	All	0.517	0.357	.004	22	view →
KICH	DFS	Median	III,IV	0.275	0.861	.002	18	view →
THCA	DFS	Median	III,IV	0.861	0.432	.030	15	view →
CESC	OS	Median	IV	0.329	0.735	.020	12	view →
OV	OS	Quartile	II,III,IV	0.301	0.411	.014	12	view →
THYM	OS	Median	All	1.000	0.732	.001	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

RAD23BP1–ACC (DFS)

Open the ACC breakdown →